Author:
Rink Michael,Schwarzenbach Heidi,Riethdorf Sabine,Soave Armin
Publisher
Springer Science and Business Media LLC
Reference91 articles.
1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA 67(1):7–30.
https://doi.org/10.3322/caac.21387
2. Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, Hernandez V, Espinos EL, Dunn J, Rouanne M, Neuzillet Y, Veskimae E, Van der Heijden AG, Gakis G, Ribal MJ (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462–475.
https://doi.org/10.1016/j.eururo.2016.06.020
3. Soave A, Engel O, Von Amsberg G, Becker A, Dahlem R, Shariat SF, Fisch M, Rink M (2015) Management of advanced bladder cancer in the era of targeted therapies. Minerva Urol Nefrol 67(2):103–115
4. Soave A, Riethdorf S, Pantel K, Fisch M, Rink M (2015) Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy? Curr Urol Rep 16(7):46.
https://doi.org/10.1007/s11934-015-0520-z
5. Oing C, Rink M, Oechsle K, Seidel C, von Amsberg G, Bokemeyer C (2016) Second line chemotherapy for advanced and metastatic urothelial carcinoma: vinflunine and beyond—a comprehensive review of the current literature. J Urol 195(2):254–263.
https://doi.org/10.1016/j.juro.2015.06.115
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献